This inventor holds 10 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Taiwan Green Point Enterprises Co., Ltd., China Medical University Hospital, Shine-On Biomedical Co., Ltd.. Active years: 2017-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
5 out of 40 
4 out of 21 
1 out of 1 Years Active: 2017-2025
Title: **Yu-Chuan Lin: Pioneering Innovations in Cancer Treatment**
Introduction
Yu-Chuan Lin, a prominent inventor based in Taichung, Taiwan, has made significant strides in the field of biotechnology with a total of 10 patents to his name. His innovative work primarily focuses on cancer treatment and immunoregulation, showcasing his commitment to advancing medical science.
Latest Patents
Among his latest contributions to the field are two remarkable patents. The first is a fusion protein and its nucleic acid encoding sequence, which can be used for treating cancer, regulating immune responses, and activating immune cells. This work demonstrates the potential of fusion proteins in therapeutic applications, as evidenced by various efficacy experiments.
The second patent involves an anti-tumor antigen nanobody and its nucleic acid encoding sequence, which specifically binds to human leukocyte antigen-G. This innovative nanobody not only provides a method for treating cancer and immune-related disorders but also offers a way to detect expression levels of HLA-G, contributing to the understanding and management of these conditions.
Career Highlights
Throughout his career, Yu-Chuan Lin has collaborated with esteemed organizations such as Taiwan Green Point Enterprises Co., Ltd. and China Medical University Hospital. These affiliations have provided platforms for his innovative research and have played a crucial role in the development and application of his patented technologies.
Collaborations
Lin has had the opportunity to work alongside talented professionals, including Der-Yang Cho and Shao-Chih Chiu. These collaborations have further enriched his research endeavors, allowing for the exchange of ideas and expertise that enhance the overall quality and impact of his work.
Conclusion
In summary, Yu-Chuan Lin stands out as a leading figure in the realm of biotechnology, particularly in cancer treatment and immunomodulation. His patents not only highlight his inventive capabilities but also promise significant advancements in medical therapies. Through continued research and collaboration, Lin is set to contribute even more to the field, ensuring his place among the notable inventors of our time.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile